Dubai PR Network, Online Press Release from Dubai and Middle East
 
Health & Fitness(Healthcare & Medicine)
Filter PR by
  

New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery – even when not treated with chemotherapy

 
New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery – even when not treated with chemotherapy

ROCHESTER, Minn. — A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy. The study was published today in the Journal of American Medical Association (JAMA).

TNBC is a breast cancer subtype that does not respond to drugs that target the estrogen receptor or the HER2 protein. It grows rapidly, is more likely to spread beyond the breast before diagnosis and is more likely to recur than other breast cancers. TNBC represents about 15% of all breast cancers and is more common in younger people and in women of African American, Hispanic and Indian descent. Immune cells, also known as tumor-infiltrating lymphocytes, or TILs, are naturally existing immune system cells that can move from the bloodstream into a tumor and can recognize and destroy cancer cells. 

'This is an important finding because it highlights that the abundance of TILs in breast tissue is a prognostic biomarker in people with early-stage triple-negative breast cancer, even when chemotherapy is not administered,' says Roberto Leon-Ferre, M.D., a breast medical oncologist at Mayo Clinic Comprehensive Cancer Center and first author of the study. 'The study's findings may inspire future clinical trials to explore whether patients with a favorable prognosis (high TILs) can avoid intensive chemotherapy regimens.'

'This meta-analysis confirms robustly the prognostic value of TILs that we have previously reported in TNBC patients treated with chemotherapy and expands it to patients treated without chemotherapy,' says Sarah Flora Jonas, Ph.D., a statistician at Gustave Roussy and co-first author of the study. 'Future studies may allow the use of this biomarker along with standard clinicopathological factors to inform treatment decisions in TNBC patients.' 

'Of interest, the first report suggesting that an increased number of immune cells being associated with better prognosis in breast cancer patients was described by doctors at Mayo Clinic more than 100 years ago,' says Roberto Salgado, M.D., co-chair of the International Immuno-Oncology Biomarker Working Group and co-lead of the study. 'It took a global effort and a century later to reexamine this biomarker and bring it closer to application in patient care.' 

'TILs are not currently measured or reported in the routine examination of tissue samples of breast cancer,' says co-senior author, Matthew Goetz, M.D., a medical oncologist at Mayo Clinic Comprehensive Cancer Center and the Erivan K. Haub Family Professor of Cancer Research Honoring Richard F. Emslander, M.D. 'While prior studies have focused on measuring TILs in people treated with chemotherapy, this is the largest study to comprehensively demonstrate that the presence of TILs influences the natural behavior of breast cancer in people who have surgery and/or radiation with no additional medical treatment.'

For this study, Mayo Clinic and Gustave Roussy researchers, in collaboration with the International Immuno-Oncology Biomarker Working Group, led 11 additional groups to collect data on 1,966 participants with early-stage TNBC who only underwent surgery with or without radiation therapy but did not receive chemotherapy. The participants had been followed for a median of 18 years. The results showed that higher levels of TILs in breast cancer tissue were associated with lower recurrence rates among participants with early-stage TNBC. 

'Five years after surgery, 95% of participants with small tumors, stage 1 TNBC, and whose tumors had high TILs were alive, compared to 82% of patients whose tumors had low TILs. Importantly, the breast cancer recurrence rate was significantly lower among patients whose tumors had high TILs,' says co-senior author, Stefan Michiels, Ph.D., head of Oncostat team, Gustave Roussy, Inserm U1018, University Paris-Saclay. 'With nearly 2,000 participants involved in the study, we have now assembled the largest international cohort across three continents of people with TNBC in which the primary treatment was surgery without chemotherapy.'

'The results of this study could lead to a recommendation to include TILs in the pathology reports of early-stage TNBC worldwide, as it has the potential to inform clinicians and patients when they discuss treatment options,' says Dr. Salgado. 

Furthermore, this biomarker would only require a visual evaluation by a pathologist looking through a microscope, meaning there are no additional costs associated with identifying the presence of immune cells. This could be particularly beneficial to regions with limited resources, adds Dr. Leon-Ferre. 

Most people with early-stage TNBC undergo chemotherapy either before or after surgery, including people with stage 1 breast cancer. Most people receive multiple chemotherapy drugs in combination, which can cause significant side effects. Currently, the main factors taken into consideration to determine the course of chemotherapy treatment for each person are the tumor size and the presence of lymph node metastases. However, the authors identified that the number of TILs further influences the risk of future recurrence.

The researchers plan to evaluate TILs as biomarkers in prospective clinical trials evaluating chemotherapy selection based on TIL levels. Ongoing efforts to conduct additional research with other potential biomarkers are underway.


Posted by : DubaiPRNetwork.com Editorial Team
Viewed 6359 times
PR Category : Healthcare & Medicine
Posted on : Monday, April 22, 2024  10:42:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Eight-year-old Emirati finds voice for first time after unde...
Next Story : Cleveland Clinic Gastroenterologist Shares Risk-Reduction an...
Email this article Print this article

Share this article with your friends and followers
NewsVine
 
 
Most Viewed Press Release posted in the last 7 days
Hat trick for Pogačar at the Giro [31226-Views]
Al Masaood Bergum Showcases Innovative Modular Solutions at Saudi Giga Projects 2024 & MEN... [29893-Views]
UAE Ministry of Finance Meets with Government Expenditure and Projects Efficiency Authorit... [29700-Views]
Pogačar prevails in Perugia time trial at Giro D'Italia [27970-Views]
Dac Is Back: António Takes The Chequered Flag To Make It Three Wins In Berlin [27753-Views]
McNulty defends US TT title as Molano top-5 in Giro D'Italia [17355-Views]
Deliverect honours top restaurants in UAE and Saudi Arabia with 0% failed orders in first ... [17294-Views]
Hitachi Energy supports long-term operation of largest HVDC-connected wind energy project ... [9172-Views]
Wonderful Indonesia Night at Raffles Dubai showcases essence of Indonesia [7601-Views]
Nissan of Arabian Automobiles Introduces the Adventure-Ready 2024 X-TRAIL N-TREK [7077-Views]
His Highness Sheikh Hamdan Bin Zayed Issues a Decree On the Air Quality System in Abu Dhab... [6626-Views]
Al Hudhud Publishing And Distribution And Emirates Literature Foundation Partner To Promot... [6392-Views]
Wings of Change: Climate-action Partnership announced to research solutions for Polar Rapt... [6252-Views]
Agility Global PLC Reports Q1 2024 Net Profit of $30.5 Million [5719-Views]
TCL Electronics set to launch latest QD-Mini LED TV and smart home appliances in Istanbul [5695-Views]
CyberHive brings a new era of cyber security protection to the UAE [5584-Views]
EDGE Signs Agreement with PT Pindad for Ammunition Production Line [5478-Views]
HE Al Olama: Nursing Profession Vital for Health Sector Sustainability, Nurses Essential f... [5441-Views]
Carrefour Announces Savings Extravaganza with “Big Brand Festival” [5387-Views]
Mubadala Energy Announces Second Consecutive Significant Gas Discovery in South Andaman, I... [5297-Views]
Deyaar posts AED 77.5 million Net Profit Before Tax, up 38% YOY in Q1 2024 [5248-Views]
Etihad Cargo Fully Prepared For UAE-PLACI [5174-Views]
Family Development Foundation launches “Kindness and Mercy” campaign to raise awareness ab... [5047-Views]
National Bonds Creates 3770 Millionaires Since Inception [4887-Views]
InterContinental Dubai Festival City Invites Guests to the Culinary Marvels in May [4871-Views]
 
RSS Facebook Twitter LinkedDin DubaiPRNetwork.com on Instagram
Back to Section Home

Related Stories

 
Top Sections
 
Top Stories